Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
429.30    0.00 (0.00%)
Bid:
424.00
Ask:
510.00
Spread: 86.00 (20.283%)
Market Cap: £10.80b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Director/PDMR Shareholding

29 Mar 2022 14:20

RNS Number : 4347G
Rentokil Initial PLC
29 March 2022
 

Rentokil Initial plc

29 March 2022

 

Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

Rentokil Initial plc (the "Company") hereby announces that the award granted under the Rentokil Initial plc Performance Share Plan in March 2019 (the "2019 PSP") for Stuart Ingall-Tombs, Chief Financial Officer (a person discharging managerial responsibility) of 44,609 shares has been automatically released with 18,967 of these shares subsequently being sold at a share price of £5.2401 to cover his tax and social security liability.

The Company further announces that the award granted under the 2019 PSP for John Myers, Managing Director, North America (a person discharging managerial responsibility) of 120,298 shares has been automatically released with 44,614 of these shares subsequently being sold at a share price of £5.2401 to cover his tax and social security liability.

Paul Cochrane (a person discharging managerial responsibility) has also exercised an award granted under the 2019 PSP with 75,557 shares subsequently sold at a share price of £5.25. Paul is retiring as Managing Director, Asia at Rentokil Initial at the end of March.

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Stuart Ingall-Tombs

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Rentokil Initial plc

b)

 

LEI

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

 

b)

 

Nature of the transaction

 

 

Release of awards made under the 2019 Performance Share Plan (PSP)

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

Nil consideration

 

44,609

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

44,609 shares

 

-

 

e)

 

Date of the transaction

 

25 March 2022

f)

 

Place of the transaction

 

Outside a trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Stuart Ingall-Tombs

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Rentokil Initial plc

b)

 

LEI

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

 

b)

 

Nature of the transaction

 

 

Sale of shares to cover the tax and social security liability arising following the release of an award made under the 2019 Performance Share Plan (PSP).

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

£5.2401

 

18,967

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Aggregated price

 

- Total

 

 

 

18,967 shares

 

£5.2401

 

£99,388.98

e)

 

Date of the transaction

 

28 March 2022

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

John Myers

2

 

Reason for the notification

 

a)

 

Position/status

 

Managing Director, North America

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Rentokil Initial plc

b)

 

LEI

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

 

b)

 

Nature of the transaction

 

 

Release of awards made under the 2019 Performance Share Plan (PSP)

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

Nil consideration

 

120,298

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

120,298 shares

 

-

 

e)

 

Date of the transaction

 

25 March 2022

f)

 

Place of the transaction

 

Outside a trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

John Myers

2

 

Reason for the notification

 

a)

 

Position/status

 

Managing Director, North America

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Rentokil Initial plc

b)

 

LEI

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

 

b)

 

Nature of the transaction

 

 

Sale of shares to cover the tax and social security liability arising following the release of an award made under the 2019 Performance Share Plan (PSP).

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

£5.2401

 

44,614

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Aggregated price

 

- Total

 

 

 

44,614 shares

 

£5.2401

 

£233,781.82

e)

 

Date of the transaction

 

28 March 2022

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Paul Cochrane

 

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Managing Director, Asia

 

 

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Rentokil Initial plc

b)

 

LEI

 

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

 

b)

 

Nature of the transaction

 

 

Exercise of awards made under the Company's 2019 Performance Share Plan (PSP).

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

Nil consideration

 

75,557

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

75,557 shares

 

 

-

 

e)

 

Date of the transaction

 

 

29 March 2022

f)

 

Place of the transaction

 

 

Outside a trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Paul Cochrane

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Managing Director, Asia

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Rentokil Initial plc

b)

 

LEI

 

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

 

b)

 

Nature of the transaction

 

 

Sale of shares.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

£5.25

 

75,557

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

- Aggregated price

 

- Total

 

 

 

 

 

75,557 shares

 

£5.25

 

£396,674.25

 

e)

 

Date of the transaction

 

 

29 March 2022

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

 

 

 

 

Enquiries:

 

Catherine Stead, Deputy Company Secretary Rentokil Initial plc 01293 858000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXGDXCBDDGDC
Date   Source Headline
19th Jul 20177:00 amRNSAppointment of Non-Executive Director
30th Jun 20178:33 amRNSCompletion of Joint Venture with Haniel
27th Jun 20175:21 pmRNSHolding(s) in Company
26th Jun 20174:54 pmRNSHolding(s) in Company
8th Jun 201711:40 amRNSFurther re Joint Venture with Haniel
7th Jun 20179:41 amRNSDirector Declaration
17th May 20175:02 pmRNSHolding(s) in Company
10th May 20174:31 pmRNSResult of AGM
10th May 20174:03 pmRNSHolding(s) in Company
10th May 201711:49 amRNSAppointment of Senior Independent Director
9th May 20175:51 pmRNSHolding(s) in Company
4th May 20174:44 pmRNSDirector/PDMR Shareholding
26th Apr 20174:27 pmRNSDirector/PDMR Shareholding
25th Apr 20175:58 pmRNSDirector/PDMR Shareholding
21st Apr 20177:00 amRNSRentokil awarded Queen's Award for Enterprise
19th Apr 20177:00 amRNSQ1 Trading Update
5th Apr 201710:43 amRNSAnnual Financial Report
31st Mar 20174:18 pmRNSTotal Voting Rights
30th Mar 20173:25 pmRNSBlock listing Interim Review
22nd Mar 20176:10 pmRNSHolding(s) in Company
9th Mar 20173:06 pmRNSAdditional Listing
28th Feb 20177:00 amRNSRentokil - Leading Pest Control Company in India
24th Feb 20172:37 pmRNSHolding(s) in Company
23rd Feb 20177:00 amRNSFinal Results
7th Feb 20177:00 amRNSAcquisition of Allgood Pest Solutions
29th Dec 20164:30 pmRNSDirector/PDMR Shareholding
16th Dec 20162:59 pmRNSHolding(s) in Company
16th Dec 20162:02 pmRNSHolding(s) in Company
16th Dec 20167:00 amRNSJoint venture with Haniel
7th Dec 20165:47 pmRNSHolding(s) in Company
7th Dec 20167:00 amRNSHolding(s) in Company
18th Nov 20161:15 pmRNSDirector Declaration
11th Nov 20165:30 pmRNSHolding(s) in Company
11th Nov 20165:10 pmRNSTotal Voting Rights
3rd Nov 20161:01 pmRNSDirector Declaration
19th Oct 20167:00 amRNSQ3 Trading Update
6th Oct 20162:58 pmRNSAdditional Listing
6th Oct 201612:31 pmRNSDirector Declaration
4th Oct 20169:49 amRNSDirector Declaration
30th Sep 20162:10 pmRNSTotal Voting Rights
29th Sep 20167:00 amRNSAdditional Listing
26th Sep 20164:48 pmRNSDirector/PDMR Shareholding
22nd Aug 20164:56 pmRNSHolding(s) in Company
28th Jul 20167:00 amRNSHalf Yearly Report
27th Jul 20167:00 amRNSCollaboration with Google and PA Consulting Group
7th Jul 20167:00 amRNSAcquisition, CDC Contract Win and Trading Update
29th Jun 20167:00 amRNSDirectorate Change
29th Jun 20167:00 amRNSDirector/PDMR Shareholding
22nd Jun 20165:27 pmRNSHolding(s) in Company
17th May 20165:06 pmRNSDirector/PDMR Shareholding - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.